# IsoTherapeutics

Type: Company

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/isotherapeutics
Canonical HTML page: https://getfinancebrief.com/entity/isotherapeutics

## Recent coverage (1 stories)

### Telix Adds ATM Facility, $68M R&D Spend in H1 2026 Results
2026-08-20 18:11:28 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

For investors, Telix's H1 2026 announcement is dominated by the same-day creation of an at-the-market equity facility with Morgan Stanley and William Blair. The release provides US$68 million in disclosed therapeutics R&D but omits revenue and profit totals in the syndicated excerpt.
Full story: https://getfinancebrief.com/story/telix-h1-2026-atm-facility-68m-rd

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.